Biochemical pharmacology

Keyphrases

Publications

volume 218, 2023

Jingyi Hu, Anqi Li, Yueyang Guo, Ting Ma, Siqi Feng
The relationship between tumor metabolism and 5-fluorouracil resistance. Biochemical pharmacology 218 (2023)
Anastasios Lymperopoulos, Jordana I Borges, Renee A Stoicovy
RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting. Biochemical pharmacology 218 (2023)
Isabel Hamshaw, Marco M D Cominetti, Wing-Yee Lai, Mark Searcey, Anja Mueller
The development of potent, competitive CXCR4 antagonists for the prevention of cancer metastasis. Biochemical pharmacology 218 (2023)
Anjaneyulu Kowluru
Regulatory roles of CARD9-BCL10-Rac1 (CBR) signalome in islet β-cell function in health and metabolic stress: Is there room for MALT1? Biochemical pharmacology 218 (2023)
Lin Xiao, Weidong Dou, Yajie Wang, Huan Deng, Hao Xu, YiSheng Pan
Corrigendum to "Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice" [Biochem. Pharmacol. 216 (2023) 115752]. Biochemical pharmacology 218 (2023)
Minyu Wang, Wanying Huang
Corrigendum to "FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway" [Biochem. Pharmacol. 218 (2023) 115893]. Biochemical pharmacology 218 (2023)

volume 217, 2023

Mengli Jin, Shuyue Zhu, Yating Tang, Xiangri Kong, Xingye Wang, Yufen Li, Shuang Jiang, Lin Wei, Chunjie Hu, Bingmei Wang, Wu Song
Ayanin, a natural flavonoid inhibitor of Caseinolytic protease, is a promising therapeutic agent to combat methicillin-resistant Staphylococcus aureus infections. Biochemical pharmacology 217 (2023)
Jindan Qi, Mei Meng, Juntao Liu, Xiaoxiao Song, Yu Chen, Yuxi Liu, Xu Li, Zhou Zhou, Xiang Huang, Xiaohua Wang, Quansheng Zhou, Zhe Zhao
Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes. Biochemical pharmacology 217 (2023)

volume 214, 2023

Yuhan Su, Tianyu Tao, Xiuxing Liu, Wenru Su
Corrigendum to "JAK-STAT signaling pathway in non-infectious uveitis" Biochemical Pharmacology 204 (2022) 115236. Biochemical pharmacology 214 (2023)
Feixiang Yang, Jiawei Li, Qintao Ge, Yuchen Zhang, Meng Zhang, Jun Zhou, Haitao Wang, Juan Du, Shenglin Gao, Chaozhao Liang, Jialin Meng
Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer. Biochemical pharmacology 214 (2023)
Sun Ruixin, Liu Yifan, Wu Chuanlong, Zhou Min, Luo Hong, Du Guoxiu, Liu Zhengyang, Sun Yansha, Dong Yiwei, Su Jingwen, Fan Mingliang, Shi Bizhi, Jiang Hua, Li Zonghai
Corrigendum to "Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer" biochemical pharmacology 212 (2023) 115536. PMID:37028461. Biochemical pharmacology 214 (2023)

volume 213, 2023

Qiuyu Pang, Lu You, Xiangmin Meng, Yumeng Li, Tian Deng, Deyong Li, Bingmei Zhu
Regulation of the JAK/STAT signaling pathway: The promising targets for cardiovascular disease. Biochemical pharmacology 213 (2023)
Sanjay Kumar, Manita Raina, Kalpana Tankay, Gaurav Milind Ingle
Patient-derived organoids in ovarian cancer: Current research and its clinical relevance. Biochemical pharmacology 213 (2023)
Siva Prasad Panda, Adarsh Kesharwani, Sarada Prasanna Mallick, Dsnbk Prasanth, Praveen Kumar Pasala, Vinay Bharadwaj Tatipamula
Viral-induced neuronal necroptosis: Detrimental to brain function and regulation by necroptosis inhibitors. Biochemical pharmacology 213 (2023)
Chen Zhang, Hao Chen, Yssa Rodriguez, Xiaowen Ma, Russell H Swerdlow, Jianhua Zhang, Wen-Xing Ding
A perspective on autophagy and transcription factor EB in Alcohol-Associated Alzheimer's disease. Biochemical pharmacology 213 (2023)
Javier Muñoz-Garcia, Dominique Heymann, Irina Giurgea, Marie Legendre, Serge Amselem, Beatriz Castañeda, Frédéric Lézot, Jorge William Vargas-Franco
Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternatives. Biochemical pharmacology 213 (2023)
Dingkun Lu, Han Jiang, Ting Zou, Yuanwang Jia, Yunyun Zhao, Zhongqun Wang
Endothelial-to-mesenchymal transition: New insights into vascular calcification. Biochemical pharmacology 213 (2023)
Man Zhu, Xiaoyu Tang, Zeren Zhu, Zhengyan Gong, Wenjuan Tang, Yu Hu, Cheng Cheng, Hongying Wang, Ammar Sarwar, Yanbin Chen, Feng Liu, Jian Huo, Xuemei Wang, Yanmin Zhang
STING activation in macrophages by vanillic acid exhibits antineoplastic potential. Biochemical pharmacology 213 (2023)
Shotaro Michinaga, Ayaka Nagata, Ryosuke Ogami, Yasuhiro Ogawa, Shigeru Hishinuma
Differential regulation of histamine H 1 receptor-mediated ERK phosphorylation by G q proteins and arrestins. Biochemical pharmacology 213 (2023)
Priyanka F Karmokar, Nader H Moniri
Free-Fatty Acid Receptor-4 (FFA4/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells. Biochemical pharmacology 213 (2023)
Qiu-Chen Bi, Zhi-Qiang Deng, Yang-Feng Lv, Yue Liu, Chuan-Sheng Xie, Yuan-Qiao He, Qun Tang
Low Pi stress enhances the sensitivity of hepatocellular carcinoma to sorafenib. Biochemical pharmacology 213 (2023)
Chunxiao He, Zhiyong Peng, Dengyang Zhang, Yao Guo, Tianqi Liang, Yuming Zhao, Liuting Yu, Qi Zhang, Zhiguang Chang, Yan Xiao, Na Li, Hongman Xue, Shunjie Wu, Zhizhuang Joe Zhao, Changhua Zhang, Yun Chen
Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia. Biochemical pharmacology 213 (2023)

volume 212, 2023

Jing Ma, Yun Xu, Min Zhang, Yi Li
Corrigendum to "Geraniol ameliorates acute liver failure induced by lipopolysaccharide/D-galactosamine via regulating macrophage polarization and NLRP3 inflammasome activation by PPAR-γ methylation Geraniol alleviates acute liver failure" [Biochem. Pharmacol. 210 (2023) 115467]. Biochemical pharmacology 212 (2023)
Rama Rao Malla, Priyamvada Bhamidipati, Meghapriya Adem
Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer. Biochemical pharmacology 212 (2023)
Xing Chang, Jingang Liu, Qian Yang, Yu Gao, Xiaofei Ding, Junjun Zhao, Yang Li, Zi Liu, Zengqiang Li, Yingliang Wu, Daiying Zuo
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT. Biochemical pharmacology 212 (2023)
Qiuyun Xue, Yurong Huang, Jun Chang, Chenglong Cheng, Yuting Wang, Xiaomei Wang, Chenggui Miao
CircRNA-mediated ceRNA mechanism in Osteoarthritis: Special emphasis on circRNAs in exosomes and the crosstalk of circRNAs and RNA methylation. Biochemical pharmacology 212 (2023)
Min Wang, Guang Zeng, Bingrui Xiong, Xiaobin Zhu, Jia Guo, Danyang Chen, Shanshan Zhang, Min Luo, Liang Guo, Lin Cai
ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma. Biochemical pharmacology 212 (2023)
Noa Raz, Aharon M Eyal, Dana Berneman Zeitouni, Danielle Hen-Shoval, Elyad M Davidson, Aviel Danieli, Merav Tauber, Yair Ben-Chaim
Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation. Biochemical pharmacology 212 (2023)
Shang-Lang Huang, Ting-Chang Chang, Nian-Kang Sun
Curcumin reduces paclitaxel resistance in ovarian carcinoma cells by upregulating SNIP1 and inhibiting NFκB activity. Biochemical pharmacology 212 (2023)
Ming Sun, Chao Wu, Lixin Liu, Liang Gu, Zihao Wang, Feng Xu, Donglin Zhu
Interplay between the renin angiotensin system and oxidative stress contributes to alcohol addiction by stimulating dopamine accumulation in the mesolimbic pathway. Biochemical pharmacology 212 (2023)
Mengyan Wang, Xiaowei Wang, Wenxia Zhao, Yang Li, Meilian Cai, Kexin Wang, Xiaoming Xi, Cong Zhao, Huimin Zhou, Rongguang Shao, Guimin Xia, Yefan Zhang, Wuli Zhao
Enhanced binding of β-catenin and β-TrCP mediates LMPt's anti-CSCs activity in colorectal cancer. Biochemical pharmacology 212 (2023)
Yanfeng Wang, Juan Zhao, Yebo Gu, Haiping Wang, Muzhou Jiang, Shuxuan Zhao, Hong Qing, Junjun Ni
Cathepsin H: Molecular characteristics and clues to function and mechanism. Biochemical pharmacology 212 (2023)
Gustavo H Oliveira-Paula, Rose I M Batista, Stephanie Stransky, Sandra C Tella, Graziele C Ferreira, Rafael L Portella, Lucas C Pinheiro, Celio Damacena-Angelis, Dario F Riascos-Bernal, Simone Sidoli, Nicholas Sibinga, Jose E Tanus-Santos
Orally administered sodium nitrite prevents the increased α-1 adrenergic vasoconstriction induced by hypertension and promotes the S-nitrosylation of calcium/calmodulin-dependent protein kinase II. Biochemical pharmacology 212 (2023)
María Paula Ceballos, Ariel Darío Quiroga, Nicolás Francisco Palma
Role of sirtuins in hepatocellular carcinoma progression and multidrug resistance: Mechanistical and pharmacological perspectives. Biochemical pharmacology 212 (2023)
Monika Saini, Che Julius Ngwa, Manisha Marothia, Pritee Verma, Shakeel Ahmad, Jyoti Kumari, Sakshi Anand, Vandana Vandana, Bharti Goyal, Soumyananda Chakraborti, Kailash C Pandey, Swati Garg, Soumya Pati, Anand Ranganathan, Gabriele Pradel, Shailja Singh
Characterization of Plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite. Biochemical pharmacology 212 (2023)
Naisarg Gamit, Arun Dharmarajan, Gautam Sethi, Sudha Warrier
Want of Wnt in Parkinson's disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling? Biochemical pharmacology 212 (2023)
Monika Saini, Che Julius Ngwa, Manisha Marothia, Pritee Verma, Shakeel Ahmad, Jyoti Kumari, Sakshi Anand, Vandana Vandana, Bharti Goyal, Soumyananda Chakraborti, Kailash C Pandey, Swati Garg, Soumya Pati, Anand Ranganathan, Gabriele Pradel, Shailja Singh
Characterization of Plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite. Biochemical pharmacology 212 (2023)
Rama Rao Malla, Priyamvada Bhamidipati, Meghapriya Adem
Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer. Biochemical pharmacology 212 (2023)
Jing Ma, Yun Xu, Min Zhang, Yi Li
Corrigendum to "Geraniol ameliorates acute liver failure induced by lipopolysaccharide/D-galactosamine via regulating macrophage polarization and NLRP3 inflammasome activation by PPAR-γ methylation Geraniol alleviates acute liver failure" [Biochem. Pharmacol. 210 (2023) 115467]. Biochemical pharmacology 212 (2023)
Menghan Wu, Aijun Wu, Xiangrui Zhang, Yang Li, Beibei Li, Shengzhe Jin, Qingyu Dong, Xiaoshuang Niu, Lihan Zhang, Xiaowen Zhou, Jiangfeng Du, Yahong Wu, Wenjie Zhai, Xiuman Zhou, Lu Qiu, Yanfeng Gao, Wenshan Zhao
Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy. Biochemical pharmacology 212 (2023)
Min Wang, Guang Zeng, Bingrui Xiong, Xiaobin Zhu, Jia Guo, Danyang Chen, Shanshan Zhang, Min Luo, Liang Guo, Lin Cai
ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma. Biochemical pharmacology 212 (2023)
Mehdi Alidadi, Ahmed Hjazi, Irfan Ahmad, Reza Mahmoudi, Masoud Sarrafha, Seyed Reza Hosseini-Fard, Mohammadreza Ebrahimzade
Exosomal non-coding RNAs: Emerging therapeutic targets in atherosclerosis. Biochemical pharmacology 212 (2023)
Samaneh Zolghadri, Mohammad Beygi, Tasneem F Mohammad, Mahdi Alijanianzadeh, Thanigaimalai Pillaiyar, Pablo Garcia-Molina, Francisco Garcia-Canovas, Jose Munoz-Munoz, Ali Akbar Saboury
Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises. Biochemical pharmacology 212 (2023)
Rama Rao Malla, Priyamvada Bhamidipati, Meghapriya Adem
Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer. Biochemical pharmacology 212 (2023)
Gustavo H Oliveira-Paula, Rose I M Batista, Stephanie Stransky, Sandra C Tella, Graziele C Ferreira, Rafael L Portella, Lucas C Pinheiro, Celio Damacena-Angelis, Dario F Riascos-Bernal, Simone Sidoli, Nicholas Sibinga, Jose E Tanus-Santos
Orally administered sodium nitrite prevents the increased α-1 adrenergic vasoconstriction induced by hypertension and promotes the S-nitrosylation of calcium/calmodulin-dependent protein kinase II. Biochemical pharmacology 212 (2023)
Ning Wei, James Burnett, Desirae L Crocker, Yixian Huang, Song Li, Peter Wipf, Edward Chu, John C Schmitz
Quassinoid analogs exert potent antitumor activity via reversible protein biosynthesis inhibition in human colorectal cancer. Biochemical pharmacology 212 (2023)
Naisarg Gamit, Arun Dharmarajan, Gautam Sethi, Sudha Warrier
Want of Wnt in Parkinson's disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling? Biochemical pharmacology 212 (2023)
Noa Raz, Aharon M Eyal, Dana Berneman Zeitouni, Danielle Hen-Shoval, Elyad M Davidson, Aviel Danieli, Merav Tauber, Yair Ben-Chaim
Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation. Biochemical pharmacology 212 (2023)
Danmei Yu, Zhou Lu, Ruyu Wang, Yusen Xiang, Hongtao Li, Jiani Lu, Lijun Zhang, Hongzhuan Chen, Weihua Li, Xin Luan, Lili Chen
FXR agonists for colorectal and liver cancers, as a stand-alone or in combination therapy. Biochemical pharmacology 212 (2023)
Márcia S Martins, Isabel F Almeida, Maria T Cruz, Emília Sousa
Chronic pruritus: From pathophysiology to drug design. Biochemical pharmacology 212 (2023)